A Measurement of Semileptonic B Decays to Narrow Orbitally-Excited Charm Mesons

The decay chain b -> Bbar -> D^{**0} l nu X, D^{**0} -> D^{*+} pi^-, D^{*+} -> D^0 pi^+, D^0 ->(Kpi or K3pi) is identified in a sample of 3.9 million hadronic Z decays collected with the OPAL detector at LEP. The branching ratio BR (b -> Bbar) x BR (Bbar -> D^0_1 l nu X) x BR (D^0_1 -> D^{*+} pi^-) is measured to be (2.64 +- 0.79 (stat) +- 0.39 (syst)) X 10^-3 for the J^P = 1^+ (D^0_1) state. For decays into the J^P = 2^+ (D^{*0}_2) state, an upper limit of 1.4 X 10^-3 is placed on the branching ratio at the 95% confidence level.Comment: 20 pages, 6 figure

Dynamic Support Culture of Murine Skeletal Muscle-derived Stem Cells Improves Their Cardiogenic Potential In Vitro

Ischemic heart disease is the main cause of death in western countries and its burden is increasing worldwide. It typically involves irreversible degeneration and loss of myocardial tissue leading to poor prognosis and fatal outcome. Autologous cells with the potential to regenerate damaged heart tissue would be an ideal source for cell therapeutic approaches. Here, we compared different methods of conditional culture for increasing the yield and cardiogenic potential of murine skeletal muscle-derived stem cells. A subpopulation of nonadherent cells was isolated from skeletal muscle by preplating and applying cell culture conditions differing in support of cluster formation. In contrast to static culture conditions, dynamic culture with or without previous hanging drop preculture led to significantly increased cluster diameters and the expression of cardiac specific markers on the protein and mRNA level. Whole-cell patch-clamp studies revealed similarities to pacemaker action potentials and responsiveness to cardiac specific pharmacological stimuli. This data indicates that skeletal muscle-derived stem cells are capable of adopting enhanced cardiac muscle cell-like properties by applying specific culture conditions. Choosing this route for the establishment of a sustainable, autologous source of cells for cardiac therapies holds the potential of being clinically more acceptable than transgenic manipulation of cells